SavedAdd your journal

Journals / Turkish Journal of Science / 2020 / Cilt: 5 - Sayı: 1

Glycated Hemoglobin (HbA1C): A Predictor of In-hospital Short Therm All Cause Mortality

Ömer TOPDAĞI
Yasemin KAYA
Oktay GULCU
İbrahim TANBOĞA
Nuri BAKAN
Pages
41–47
Publication Date
2020-03-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the model 1 in multivariate analysis, there was a significant correlation between HbA1c level and in-hospital mortality (uncorrected OR: 1.216, 95% CI 1.116-1.326, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background & objectives: HbA1c shows the mean glucose level in blood and is a biochemical parameter used in follow-up and diagnosis of diabetic patients.
📊
Key Findings & Data:We aimed to investigate the association between HbA1c and in-hospital all cause mortality in diabetic patients who were admitted due to any diagnosis.
💡
Conclusion & Impact:In the model 1 in multivariate analysis, there was a significant correlation between HbA1c level and in-hospital mortality (uncorrected OR: 1.216, 95% CI 1.116-1.326, p
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Tip 2 Diabetes Mellitus · HbA1c · In hospital mortality

Abstract

Background & objectives: HbA1c shows the mean glucose level in blood and is a biochemical parameter used in follow-up and diagnosis of diabetic patients. We aimed to investigate the association between HbA1c and in-hospital all cause mortality in diabetic patients who were admitted due to any diagnosis. Methods: 3207 diabetic patients included study who had been diagnosed with diabetes mellitus. Trauma patients, type 1 diabetes were excluded. Patients’ age, gender, admission diagnosis, duration of hospitalization, whether they died in-hospital, laboratory parameters and HbA1c levels were recorded. Results: The mean age of patients was 50.53±17 years with 59.7% (n:1913) being females. Patients who died in hospital had higher HbA1c, age, BUN (blood urea nitrogen), creatine and uric acid levels according to the Univariate analysis (p=0.000, p=0.000; p=0.004, p=0.04, p=0.03; respectively). In the model 1 in multivariate analysis, there was a significant correlation between HbA1c level and in-hospital mortality (uncorrected OR: 1.216, 95% CI 1.116-1.326, p

🔖

Cite This Article

TOPDAĞI, Ö., KAYA, Y., GULCU, O., TANBOĞA, İ., BAKAN, N. (2020). Glycated Hemoglobin (HbA1C): A Predictor of In-hospital Short Therm All Cause Mortality. Turkish Journal of Science, Cilt: 5 - Sayı: 1, 41–47. https://ajindex.com/articles/809507

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Skriver MV, Sandbæk A, Kristensen JK, H Stovring. Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospectiveobservational study. BMJ Open Diabetes Research and Care 2015;2: 1-8
  2. Wolsk E, Claggett B, Pfeffer MA, Diaz R, Dickstein K, Gerstein HC, et al. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus J Am Heart Assoc 2017; 29:1-11
  3. Nilsson E, Carrero JJ, Heimbürger O, Hellberg O, Lindholm B, Stenvinkel P. A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients. Clinical Kidney Journal 2016; 9: 148–152
  4. Thomas L. Christoph MN, Hans R. Glycohemoglobins. Clinical Laboratory Diagnostics 1998;142-148
  5. Rahbar S. An abnormal hemoglobin in red cells of diabetics. Clin Chem 1968;22:296-308
  6. Krishnamurti U, Steeffes MW. Glycohemoglobin: A primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem 2001;47:1157-1165
  7. Saudek CD, Rastogi R, Derr RL. Assesment of glycemia in diabetes mellitus: Hemoglobin A1c. J Assoc Physicians India 2005;53:299-304
  8. Zhong GC, Ye1 MX, Cheng JH, Zhao Y, Gong JP. HbA1c and Risks of All-Cause and Cause-Specific Death in Subjects without Known Diabetes: A Dose-Response Meta-Analysis of Prospective Cohort Studies. Scientific Reports 2016;6:24071
  9. Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD. HbA1c measurement improves the detection of type 2 diabetes in high risk individuals with nondiagnostic levels of fasting plasma glucose. Diabetes Care 2001 24:465-471
  10. Li W, Katzmarzyk PT, Horswel R, Wang Y, Jhonson J, Hu G. HbA1c and all-cause mortality risk among patients with type 2 diabetes. Int J Cardiol 2016;202:490–496
  11. Bancks MP, Odegaard AO, Pankow JS, Khon WP, Yuan JM, Gross MD, et al. Glycated hemoglobin and all-cause and cause-specific mortality in Singaporean Chinese without diagnosed diabetes: The Singapore Chinese Health Study. Diabetes Care 2014;37:3180–3187
  12. Sakuraı M, Saıtoh S, Mıura K, Nakagawa H, Ohnıshı H, Akasaka H, et al. HbA1c and the risks for all-cause and cardiovascular mortality in the general Japanese population: NIPPON DATA 90. Diabetes Care 2013; 36: 3759–3765
  13. Zhang Y, Hu G, Yuan Z, Chen L. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with